scholarly journals Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells

Blood ◽  
1978 ◽  
Vol 52 (6) ◽  
pp. 1099-1114 ◽  
Author(s):  
YK Ho ◽  
RG Smith ◽  
MS Brown ◽  
JL Goldstein
Keyword(s):  
Acute Myelogenous Leukemia ◽  
Low Density Lipoprotein ◽  
Ldl Receptor ◽  
Density Lipoprotein ◽  
Receptor Activity ◽  
Myelogenous Leukemia ◽  
Leukemia Cells ◽  
Low Density ◽  
Acute Myelogenous

scholarly journals Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation

Blood ◽  
1984 ◽  
Vol 63 (5) ◽  
pp. 1186-1193 ◽  
Author(s):  
S Vitols ◽  
G Gahrton ◽  
A Ost ◽  
C Peterson
Keyword(s):  
Bone Marrow ◽  
Peripheral Blood ◽  
Lymphoblastic Leukemia ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Receptor Activity ◽  
Myelogenous Leukemia ◽  
Leukemic Cells ◽  
Low Density ◽  
Degradation Rates

Abstract The receptor-mediated degradation of 125I-low density lipoprotein (LDL) was compared in normal white blood cells and leukemic cells. The cells were isolated from the peripheral blood and bone marrow of healthy subjects and patients with newly diagnosed leukemia. The cells from most of the 40 consecutive patients with acute myelogenous leukemia showed markedly higher degradation rates as compared to mononuclear cells and granulocytes from peripheral blood and nucleated cells from the bone marrow of healthy individuals. Leukemic cells from patients with monocytic (FAB-M5) or myelomonocytic leukemia (FAB-M4) exhibited the highest degradation rates. The rate of receptor-mediated degradation of 125I-LDL was also high in leukemic cells from all three patients with chronic myelogenous leukemia in blast crisis, as well as in two of three patients with acute undifferentiated leukemia. In contrast, leukemic cells isolated from two patients with acute lymphoblastic leukemia showed low rates. In most cases, there was little difference in LDL receptor activity between leukemic cells isolated from peripheral blood and those from bone marrow. Hypocholesterolemia was a frequent finding in the leukemic patients. There was an inverse correlation between the plasma cholesterol level and the rate of receptor-mediated degradation of 125I-LDL by the leukemic cells. Studies are now in progress to investigate the possibilities of using LDL as a carrier of cytotoxic drugs in the treatment of leukemia.

scholarly journals A study of the chylomicron metabolism in WHHL rabbits after fat loading. Discrepancy between results based on measurement of apoprotein B-48 or retinyl palmitate

1992 ◽  
Vol 285 (2) ◽  
pp. 641-646 ◽  
Author(s):  
P N M Demacker ◽  
P J van Heijst ◽  
A F H Stalenhoef
Keyword(s):  
New Zealand ◽  
Strong Correlation ◽  
Low Density Lipoprotein ◽  
Ldl Receptor ◽  
Density Lipoprotein ◽  
Retinyl Palmitate ◽  
Receptor Activity ◽  
Low Density ◽  
Apoprotein B ◽  
Chylomicron Metabolism

We studied the metabolism of chylomicrons in homozygous Watanabe heritable hyperlipidaemic (WHHL) rabbits and in cholesterol-fed or normally fed New Zealand White (NZW) rabbits by measuring the concentrations of apoprotein B-48 and of retinyl palmitate in their serum after feeding fat plus this vitamin according to two different protocols. Compared with NZW controls, retinyl palmitate accumulated in both hyperlipidaemic groups under study, not only in the d less than 1.019 fraction but also in the low-density lipoprotein (LDL) fraction. A strong correlation was found between the retinyl palmitate concentration in either the d less than 1.019 fraction or the LDL fraction of the WHHL rabbits and the concentrations of cholesterol and triacylglycerols in these fractions. This suggests that retinyl palmitate is exchanged rapidly between exogenous and endogenous lipoproteins. This is supported by the lack of a correlation between the retinyl palmitate concentrations and the intensity of the apoprotein B-48 band in the respective d less than 1.019 fractions or LDL fractions; in most fractions, in which large amounts of retinyl palmitate were present, the intensity of the apoprotein B-48 band was not increased compared with the fasting concentrations. Assuming that retinyl palmitate is a marker for the transfer of exogenous lipids, the results of our experiments indicate that the removal of exogenous lipids is delayed by complexing to endogenously synthesized lipoproteins. However, the clearance of apoprotein B-48 is normal and thus independent of the LDL-receptor activity.

scholarly journals Addition of a mannose-6-phosphate-containing oligosaccharide alters cellular processing of low density lipoprotein by parental and LDL-receptor-defective Chinese hamster ovary cells

1984 ◽  
Vol 68 (1) ◽  
pp. 183-194
Author(s):  
A.M. Leichtner ◽  
M. Krieger
Keyword(s):  
Chinese Hamster Ovary ◽  
Cho Cells ◽  
Low Density Lipoprotein ◽  
Chinese Hamster ◽  
Ldl Receptor ◽  
Density Lipoprotein ◽  
Receptor Activity ◽  
Low Density ◽  
Cellular Processing ◽  
Mannose 6 Phosphate

Low density lipoprotein (LDL) was chemically modified by the addition of omega-(6-phospho)-tetra(alpha 1–3)mannosyl-(alpha 1–2)mannose (M56P), a phosphorylated oligosaccharide containing a terminal mannose 6-phosphate residue. Uptake and degradation of this modified LDL (M56P-LDL) by Chinese hamster ovary (CHO) cells occurred via the lysosomal enzyme (mannose 6-phosphate) receptor pathway. Cellular processing of M56P-LDL was saturable, specific for the mannose 6-phosphate marker, and occurred with approximately threefold higher affinity than that of native LDL by the LDL receptor pathway. Mannose 6-phosphate receptor activity, as measured by degradation of M56P-LDL, was ninefold lower than the LDL receptor activity. Degradation of M56P-LDL was more sensitive to inhibition by the lysosomotropic agent chloroquine than was degradation of LDL, suggesting differences in the intracellular processing of mannose 6-phosphate-bearing ligands and LDL. Previously isolated CHO cell lines defective in LDL receptor activity resembled parental CHO cells in their ability to process M56P-LDL. The potential use of M56P-LDL in the isolation of cells with pleiotropic mutations affecting receptor-mediated endocytosis is discussed.

Sign in / Sign up

Export Citation Format

Share Document